What is a hemodynamic consequence of carbon dioxide (CO2) pneumoperitoneum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The hemodynamic consequence of carbon dioxide pneumoperitoneum is an increase in systemic vascular resistance. When carbon dioxide is insufflated into the peritoneal cavity during laparoscopic procedures, it creates increased intra-abdominal pressure that affects cardiovascular function. This elevated pressure can lead to increased mean arterial pressure, central venous pressure, and systemic vascular resistance, which can impair cardiac function 1. The absorption of carbon dioxide from the peritoneal cavity can also cause hypercapnia, leading to sympathetic stimulation that typically increases systemic vascular resistance and mean arterial pressure rather than decreasing them.

Some key points to consider include:

  • Increased intra-abdominal pressure due to pneumoperitoneum can reduce venous return to the heart, potentially decreasing cardiac preload and cardiac index 1.
  • However, the most recent and highest quality evidence suggests that the primary hemodynamic consequence is an increase in systemic vascular resistance, rather than a decrease in cardiac index or mean arterial pressure 1.
  • Anesthesiologists and surgeons should be aware of these hemodynamic changes during laparoscopic procedures and may need to adjust fluid management, ventilation parameters, or positioning to mitigate these effects, particularly in patients with limited cardiac reserve.
  • Maintaining muscle relaxation of the abdominal muscles and reducing intra-abdominal pressure below 10-12 mmHg may help reduce the physiological effects of pneumoperitoneum and improve renal blood flow and cardiac function 1.

From the Research

Hemodynamic Consequences of Carbon Dioxide Pneumoperitoneum

  • The hemodynamic effects of carbon dioxide pneumoperitoneum have been studied in various settings, including laparoscopic cholecystectomy 2, 3 and laparoscopic donor nephrectomy 4.
  • The studies have shown that carbon dioxide pneumoperitoneum can cause:
    • Increase in mean arterial pressure (MAP) and systemic vascular resistance (SVR) 4, 5
    • Decrease in stroke volume (SV) and cardiac output (CO) 4
    • Increase in central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP) 2, 3
    • Decrease in cardiac index (CI) 3
  • However, the effects of carbon dioxide pneumoperitoneum on hemodynamics can be influenced by various factors, such as:
    • Intra-abdominal pressure (IAP) 4
    • Positioning of the patient 2
    • Ventilation protocol 6
  • In some studies, low-pressure carbon dioxide pneumoperitoneum (IAP ≤ 5 mmHg) has been shown to have minimal effects on hemodynamics in young children 6.
  • The hemodynamic changes caused by carbon dioxide pneumoperitoneum can be reversed after desufflation 3, 5.

Related Questions

What is the most direct hemodynamic consequence of carbon dioxide (CO2) pneumoperitoneum?
What is the most likely hemodynamic consequence of carbon dioxide (CO2) pneumoperitoneum?
What happens to mean arterial pressure and systemic vascular resistance during CO2 (carbon dioxide) pneumoperitoneum?
What is the next action if hypotension develops after pneumoperitoneum and trocar placement for laparoscopic cholecystectomy (surgical removal of the gallbladder using a minimally invasive technique)?
What is the next action when hypotension develops after pneumoperitoneum (inflation of the abdominal cavity with gas) and trocar (surgical instrument) placement for laparoscopic (minimally invasive surgical procedure using a laparoscope) cholecystectomy (surgical removal of the gallbladder)?
Can Mebendazole (MBZ) be taken with Lenvatinib (Lenvima) and Pembrolizumab (Pembro, Keytruda)?
Does a 55-year-old patient on levothyroxine (T4) 75 micrograms require a dosage increase due to elevated Thyroid-Stimulating Hormone (TSH) levels?
What is the most likely bacterial isolate in a postoperative patient with hyperthermia and foul-smelling wound drainage on postoperative day 1?
Can patients receiving Bacillus Calmette-Guérin (BCG) intravesical therapy experience hematuria?
Can patients receiving Bacillus Calmette-Guérin (BCG) intravesical therapy experience hematuria?
What anticoagulant is recommended for nonocclusive subsegmental pulmonary emboli (PE) in the distal segmental branches of the pulmonary arteries?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.